Zydus Lifesciences gets tentative approval from USFDA for BP lowering drug

Zydus Lifesciences announced on Thursday that it has received tentative approval from the US Food and Drug Administration (USFDA) to market its generic Azilsartan Medoxomil tablets, which are used to treat high blood pressure. The USFDA's tentative approval covers Azilsartan Medoxomil tablets in strengths of 40 mg and 80 mg.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zzsh1ad
via IFTTT